Table 1: Antibiotic Resistance for Most
Common Pathogens
Data
are expressed as total number of pathogen tested (Percentage resistant)
Antimicrobials |
Organisms |
|||||||||
Acinetobacter |
Klebsiella |
Pseudomonas |
Others |
Esherechia coli |
||||||
Amikacin |
254 |
(73.6%) |
274 |
(25.5%) |
135 |
(63.7%) |
186 |
(49.5%) |
130 |
(10.8%) |
Gentamicin/Tobramycin |
252 |
(75.0%) |
282 |
(64.2%) |
145 |
(72.4%) |
338 |
(69.5%) |
142 |
(41.5%) |
Cefepime |
241 |
(96.3%) |
282 |
(98.2%) |
134 |
(97.8%) |
183 |
(82.0%) |
136 |
(94.9%) |
Ceftezidime |
247 |
(93.1%) |
276 |
(98.9%) |
152 |
(94.7%) |
187 |
(87.7%) |
137 |
(94.9%) |
Cefotaxime |
57 |
(94.7%) |
69 |
(98.6%) |
27 |
(100.0%) |
63 |
(92.1%) |
45 |
(95.6%) |
Cefuroxime |
242 |
(100.0%) |
285 |
(99.6%) |
13 |
(100.0%) |
207 |
(95.6%) |
146 |
(97.2%) |
Ceftriaxone |
79 |
(100.0%) |
76 |
(98.7%) |
13 |
(100.0%) |
64 |
92.2%) |
37 |
(95.6%) |
Ceftazidime |
252 |
(92.3%) |
277 |
(99.3%) |
150 |
(94.7%) |
197 |
(87.3%) |
141 |
(95.7%) |
Imipenem |
211 |
(99.1%) |
258 |
(14.7%) |
151 |
(88.7%) |
186 |
(23.7%) |
127 |
(6.3%) |
Meropenem |
243 |
(97.9%) |
252 |
(16.3%) |
149 |
(87.9%) |
172 |
(18.6%) |
122 |
(6.6%) |
Tazocin |
66 |
(98.5%) |
135 |
(66.7%) |
85 |
(60.0%) |
90 |
(24.4%) |
65 |
(30.8%) |
Methicillin |
0 |
0 |
3 |
(66.7%) |
0 |
0 |
28 |
(92.9%) |
31 |
(90.3%) |
Ampicillin |
240 |
(99.58%) |
283 |
(100.0%) |
9 |
(100.0%) |
239 |
(98.7%) |
141 |
(100.0%) |
Levofloxacin |
100 |
(96.0%) |
116 |
(56.9%) |
70 |
(68.6%) |
131 |
(56.5%) |
62 |
(69.4%) |
Ciprofloxacin |
244 |
(97.1%) |
281 |
(76.5%) |
150 |
(76.0%) |
347 |
(78.7%) |
148 |
(76.4%) |
Vancomycin |
1 |
0 |
0 |
0 |
0 |
0 |
179 |
(28.5%) |
0 |
0 |
Rifampicin |
3 |
(66.7%) |
1 |
(100.0%) |
0 |
0 |
158 |
(30.4%) |
0 |
0 |